Security record
CTLT
Catalent, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
15Tracked holders
0Δ holders
28.60MShares held
$1.73BReported value
+1New positions
−1Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -11.3% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2024 | 15 | 0 | 28.60M | $1.73B | +1 | −1 |
| Q2 2024 | 15 | — | 32.25M | $1.81B | — | — |
Who holds it · Q3 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 6.40M | +30.3% | $387.56M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 2 | Norges Bank ✦ (passive) | 4.79M | +4.3% | $289.90M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Millennium Management ✦ | 4.52M | +10.7% | $273.65M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 4.27M | -1.0% | $257.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 4.27M | -1.0% | $257.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Elliott Investment Management ✦ | 4.00M | 0.0% | $242.28M | 2.3% | Held | 2 | SEC ↗ |
| 7 | Marshall Wace ✦ | 1.38M | -22.8% | $83.88M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 8 | Marshall Wace ✦ | 1.38M | -22.8% | $83.88M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 9 | Marshall Wace ✦ | 1.38M | -22.8% | $83.88M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 1.16M | -41.0% | $70.16M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 1.16M | -41.0% | $70.16M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 1.05M | -22.1% | $63.51M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 364.54K | +39.7% | $22.08M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 285.30K | New | $17.28M | 0.0% | New | 1 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 285.16K | -94.2% | $17.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 285.16K | -94.2% | $17.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 60.38K | +1242.3% | $3.66M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | GAMCO Investors ✦ | 25.25K | -5.1% | $1.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 12.38K | +16.0% | $746,018 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 12.38K | +16.0% | $746,018 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Wellington Management ✦ | 8.59K | -10.3% | $519,994 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | Wellington Management ✦ | 8.59K | -10.3% | $519,994 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $17.28M | 0.0% |
Exited
| Bridgewater Associates | $1.92M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 1 shares, $63 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2024 ·
Methodology ·
Get this via the API